You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.43 KDa. Observed: 34-48 KDa, reducing conditions
Human
Gln62-Ile291
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.38 KDa. Observed: 30-38 KDa, reducing conditions
Human
Thr19-Met233
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.36 KDa. Observed: 60 KDa, reducing conditions
Human
Ala19-Val367
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 35.2 KDa. Observed: 55 KDa, reducing conditions
Human
Ala23-Ala344
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 37.6 KDa. Observed: 50-65 KDa, reducing conditions
Human
Asp22-Gln118
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 26.88 KDa. Observed: 35 KDa, reducing conditions
Human
Gln22-Ile265
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.38 KDa. Observed: 28 KDa, reducing conditions
Human
Leu39-Val202
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (Regularly tested)
Predicted: 61.6 KDa. Observed: 70-150&38 KDa, reducing conditions
Human
Gln25-His559
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.22 KDa. Observed: 73 KDa, reducing conditions
Human
Ala22-Ile350
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.7 KDa. Observed: 30-40 KDa, reducing conditions
Human/Cynomolgus
Asn19-Pro152
N-6His
10 μg, 50 μg, 500 μg, 1 mg